TBPH today
$17.03+$0.00 (+0.00%)close Sep 23, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourLeaning Bearish
15 minLeaning Bearish
5 minDescending Triangle
Daily trend turns up above $19.37
Key levels
Resistance$17.17
Resistance$17.11
Support$17.02
Support$16.96
Nasdaq · Healthcare
Theravance Biopharma, Inc. (TBPH)
What Is the Price Target for TBPH?
SEPT Low Target
$14.45
SEPT Mid Target
$17.00
SEPT High Target
$19.55
Analyst Consensus
$17.00
Is TBPH a Buy or Sell Right Now?
Thesis
- •Revenue growing 66.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TBPH.
Start Free Trial →Is TBPH Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$25.89
51
Moat Score
NARROW
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with TBPH?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Winningham Rick E | director officer | Sale | 1,382,272 | - | Sep 23, 2026 |
| Winningham Rick E | director officer | Sale | 151,875 | - | Sep 23, 2026 |
| Winningham Rick E | director officer | Sale | 76,875 | - | Sep 23, 2026 |
| Winningham Rick E | director officer | Sale | 23,400 | - | Sep 23, 2026 |
| Winningham Rick E | director officer | Sale | 92,567 | - | Sep 23, 2026 |
| PAKIANATHAN DEEPIKA | director | Sale | 58,065 | - | Sep 23, 2026 |
| PAKIANATHAN DEEPIKA | director | Sale | 6,009 | - | Sep 23, 2026 |
| MITCHELL DEAN J | director | Sale | 91,204 | - | Sep 23, 2026 |
| MITCHELL DEAN J | director | Sale | 6,009 | - | Sep 23, 2026 |
| Miller Aine | officer | Sale | 93,108 | - | Sep 23, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TBPH Growth Story
Revenue YoY
66.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
279.13%
FCF Growth YoY
2109.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for TBPH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TBPH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:31:23 | $17.05 | 5,500 | $$94K | BUY |
| 20:31:06 | $17.05 | 5,500 | $$94K | BUY |
| 20:24:18 | $17.05 | 5,372 | $$92K | SELL |
| 20:24:18 | $17.05 | 4,628 | $$79K | SELL |
| 20:12:30 | $17.05 | 6,781 | $$116K | SELL |
5 dark pool trades shown · $$474K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Theravance Biopharma, Inc. (TBPH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TBPH — frequently asked questions
What is TBPH stock price today?
Theravance Biopharma, Inc. (TBPH) is at $17.03, up 0.00% (+$0.00) at the Sep 23, 2026 close.
Why is TBPH stock moving today?
Latest TBPH news — Sep 24, 2026: BTIG Halts Coverage Stance for Theravance Biopharma
What is the TBPH price target?
The average analyst price target for TBPH is $17.00, ranging from $17 to $17, based on 1 analysts. Latest: B. Riley Securities maintains on Apr 7, 2026.
What do analysts rate TBPH?
Analyst ratings for TBPH: 0 Buy, 1 Hold, 2 Sell — consensus Sell.
Did TBPH beat earnings?
TBPH last reported on Aug 10, 2026: EPS -$0.11 vs $0.07 expected — a miss of 251.7%.
What is TBPH's P/E ratio?
TBPH trades at a P/E of 8.3.
Does TBPH pay a dividend?
TBPH does not currently pay a dividend.
What are TBPH support and resistance levels?
Support: $17.02, $16.96, $16.80. Resistance: $17.11, $17.17, $17.25.
What are insiders doing with TBPH?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on TBPH?
Sep 24, 2026: BTIG Halts Coverage Stance for Theravance Biopharma